Current Cardiovascular Imaging Reports

, Volume 4, Issue 2, pp 98–107

Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

  • Suzanne de Waha
  • Georg Fuernau
  • Ingo Eitel
  • Philipp Lurz
  • Steffen Desch
  • Gerhard Schuler
  • Holger Thiele
Article

DOI: 10.1007/s12410-011-9069-5

Cite this article as:
de Waha, S., Fuernau, G., Eitel, I. et al. Curr Cardiovasc Imaging Rep (2011) 4: 98. doi:10.1007/s12410-011-9069-5

Abstract

Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.

Keywords

Cardiac magnetic resonance imagingClinical trialsOutcome measures

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Suzanne de Waha
    • 1
  • Georg Fuernau
    • 1
  • Ingo Eitel
    • 1
  • Philipp Lurz
    • 1
  • Steffen Desch
    • 1
  • Gerhard Schuler
    • 1
  • Holger Thiele
    • 1
  1. 1.Department of Internal Medicine/CardiologyUniversity of Leipzig – Heart CenterLeipzigGermany